Search research articles
Contact Us
Filters
Showing results (1-10 of 311) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Metastasis-Targeted Therapy: Ready for Phase III?
Bertrand Tombal
Nature Reviews. Urology
|
April 25, 2012
Prostate cancer: Bone Scan Index made easy, at last
Bertrand Tombal
European Journal of Cancer (Oxford, England : 1990)
|
September 28, 2011
Chairperson's introduction: Prostate cancer (PCa) is the most frequently detected cancer in the European Union in men above 50 years of age
Bertrand Tombal
The Lancet. Oncology
|
December 5, 2019
Androgen receptor-targeted agents in the management of advanced prostate cancer
Bertrand Tombal
European Urology
|
November 13, 2017
Assembling the Puzzle of Advanced Prostate Cancer: Lessons from GETUG-AFU 15
Bertrand Tombal
European Urology
|
March 21, 2014
Words of wisdom: Re: Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trials
Bertrand Tombal
European Urology
|
June 9, 2014
Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy
Bertrand Tombal
European Urology
|
December 14, 2011
Continuous improvement versus innovation: the case for sipuleucel-T
Bertrand Tombal
European Urology
|
March 27, 2014
Zometa European Study (ZEUS): another failed crusade for the holy grail of prostate cancer bone metastases prevention?
Bertrand Tombal
European Urology
|
January 19, 2007
Docetaxel and beyond
Bertrand Tombal
Page
of 32
Search research articles
Search
Showing results (1-10 of 311) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Metastasis-Targeted Therapy: Ready for Phase III?
Bertrand Tombal
Nature Reviews. Urology
|
April 25, 2012
Prostate cancer: Bone Scan Index made easy, at last
Bertrand Tombal
European Journal of Cancer (Oxford, England : 1990)
|
September 28, 2011
Chairperson's introduction: Prostate cancer (PCa) is the most frequently detected cancer in the European Union in men above 50 years of age
Bertrand Tombal
The Lancet. Oncology
|
December 5, 2019
Androgen receptor-targeted agents in the management of advanced prostate cancer
Bertrand Tombal
European Urology
|
November 13, 2017
Assembling the Puzzle of Advanced Prostate Cancer: Lessons from GETUG-AFU 15
Bertrand Tombal
European Urology
|
March 21, 2014
Words of wisdom: Re: Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trials
Bertrand Tombal
European Urology
|
June 9, 2014
Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy
Bertrand Tombal
European Urology
|
December 14, 2011
Continuous improvement versus innovation: the case for sipuleucel-T
Bertrand Tombal
European Urology
|
March 27, 2014
Zometa European Study (ZEUS): another failed crusade for the holy grail of prostate cancer bone metastases prevention?
Bertrand Tombal
European Urology
|
January 19, 2007
Docetaxel and beyond
Bertrand Tombal
Page
of 32